Intas Pharmaceuticals Limited Docetaxel Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Docetaxel Export Records India — #4 Exporter, 44 Shipments, $2.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Docetaxel

India Pharmaceutical Trade Intelligence

$39.6M253 Suppliers120 CountriesHS 30049044

ExportsIndia → UNITED STATES26.6%India → AFGHANISTAN10.1%

ImportsGERMANY → India$266.0K SINGAPORE → India$165.7K

#1 Supplier: FRESENIUS KABI #1 Buyer: MYLAN INSTITUTIONAL

Intas Pharmaceuticals Limited — Docetaxel Exporter #4 | $2.2M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Docetaxel Exporter Profile

Indian Pharmaceutical Exporter · #4 for Docetaxel · $2.2M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #4 Indian exporter of Docetaxel with $2.2M in export value and 44 verified shipments. Intas Pharmaceuticals Limited holds a 5.6% market share in Docetaxel exports across 9 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Docetaxel Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Docetaxel export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Docetaxel?

Country	Value	Shipments	Share
MEXICO	$300.0K	6	23.0%
AUSTRALIA	$270.3K	8	20.7%
KOREA,REPUBLIC OF	$200.0K	4	15.3%
SOUTH AFRICA	$124.6K	3	9.6%
PHILIPPINES

Who Are the Top Buyers of Docetaxel from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	SOUTH AFRICA	$227.2K	7
TO INDUSTRIAL BANK OF KOREA	KOREA,REPUBLIC OF	$150.0K	3
INDUSTRIAL BANK OF KOREA	REPUBLIC OF KOREA	$150.0K	3
ACCORD HEALTHCARE PTY LTD	AUSTRALIA	$120.3K	5
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$100.0K	2
ACCORD FARMA S A DE C V	MEXICO	$100.0K	2
TO THE ORDER .	AUSTRALIA	$100.0K	2
ACCORD HEALTHCARE LTD (PHILIPPINES)	PHILIPPINES	$69.0K	7
ACCORD HEALTHCARE C/O QESTMED (PTY)	SOUTH AFRICA	$50.0K	1
TO INDUSTRIAL BANK	SOUTH KOREA	$50.0K	1

Intas Pharmaceuticals Limited supplies Docetaxel to 17 buyers globally. The largest buyer is TO THE ORDER (SOUTH AFRICA), followed by TO INDUSTRIAL BANK OF KOREA (KOREA,REPUBLIC OF) and INDUSTRIAL BANK OF KOREA (REPUBLIC OF KOREA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Docetaxel Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUG&MED: TAXANIT RTU 4 ML (20 mg/ml, 4ml) TAXANIT RTU 4 ML INJECTION EACH ML CONTAINS: DOCETAXEL ANHYDROUS PH.EU	$150.0K	3
PHARMA DRUGS AND MEDI ACCORD DOCETAXEL20	$100.0K	2
PHARMA DRUGS AND MEDI ACCORD DOCETAXEL20MG ML 1ML AS PER INV	$100.0K	2
PHARMA DRUGS AND MEDI TAXANIT RTU 4 ML 20 MG/ML 4ML TAXANIT RTU 4 ML INJECTION EACH ML CONTAINS: DOCETAXEL ANHYDROUS	$100.0K	2
PHARMA DRUGS & MEDI DOCETAXEL ACCORD 160	$73.5K	3
PHARMACEUTICAL DRUGS AND MEDICINE-TAXTASDOCETAXEL20MG/ML 4ML 1V(AC-PHP) EACH MLCONTAINSCOLON DOCETAXEL ANHYDROUS	$59.9K	4
PHARMACEUTICAL DRUGS AND MEDICINE DOCETAXEL ACCORD 80MG 4 ML AS PER INVOICE	$50.0K	1
PHR DRUGS&MEDI DOCETAXEL INJECTION USP 2	$50.0K	1
PHA.DRU & MEDI, DOCETAXEL INJECTION 20 m	$50.0K	1
PHARMACEUTICAL DRUGS AND MEDICINE : ACCORD DOCETAXEL20MG/ML-4ML 1X1V S.KOREA Each mL contains Docetaxel anhydrous Ph.	$50.0K	1

Intas Pharmaceuticals Limited exports 28 distinct Docetaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUG&MED: TAXANIT RTU 4 ML (20 mg/ml, 4ml) TAXANIT RT with 3 shipments worth $150.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Docetaxel Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	FRESENIUS KABI ONCOLOGY LIMITED	$8.4M	356	21	$23.5K
2	MYLAN LABORATORIES LIMITED	$3.5M	69	1	$50.0K
4	INTAS PHARMACEUTICALS LIMITED ★	$2.2M	44	9	$50.0K
8	EUGIA PHARMA SPECIALITIES LIMITED	$1.1M	88	2	$12.6K
9	NV REMEDIES PRIVATE LIMITED	$959.1K	27	4	$35.5K

Intas Pharmaceuticals Limited ranks #4 among 253 Indian Docetaxel exporters. Average shipment value of $50.0K compared to the market average of $88.6K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Docetaxel Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	530	20.1%
DELHI AIR	416	15.8%
SAHAR AIR CARGO ACC (INBOM4)	379	14.4%
SAHAR AIR	372	14.1%
Bombay Air	132	5.0%
Delhi Air	90	3.4%
HYDERABAD AIR	79	3.0%
HYDERABAD ACC (INHYD4)	54	2.1%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Docetaxel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Docetaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 45 individual customs records matching Intas Pharmaceuticals Limited exporting Docetaxel, covering 28 formulations to 11 countries via 17 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 120+ countries, 641+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Docetaxel

Docetaxel

Intas Pharmaceuticals Limited — Docetaxel Exporter Profile

Intas Pharmaceuticals Limited — Docetaxel Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Docetaxel?

Who Are the Top Buyers of Docetaxel from Intas Pharmaceuticals Limited?

What Is India's Total Docetaxel Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Docetaxel Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Docetaxel Exporters?

What Docetaxel Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Docetaxel to Key Markets

Mexico — COFEPRIS

Australia — TGA

How Does Intas Pharmaceuticals Limited Compare to Nearest Docetaxel Exporters?

Which Indian Ports Ship Docetaxel Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Docetaxel Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Docetaxel Export Data from Intas Pharmaceuticals Limited

Docetaxel Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source